Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Evogene Ltd. stock logo
EVGN
Evogene
$0.38
+0.2%
$0.46
$0.35
▼
$1.30
$3.27M1.441.10 million shs10,159 shs
CVR Partners, LP stock logo
UAN
CVR Partners
$125.72
+0.9%
$127.84
$93.43
▼
$139.50
$1.33B0.2654,323 shs7,234 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Evogene Ltd. stock logo
EVGN
Evogene
+2.91%+1.08%-1.47%-23.50%-71.42%
CVR Partners, LP stock logo
UAN
CVR Partners
+1.02%-1.51%+1.51%-2.13%+36.45%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Evogene Ltd. stock logo
EVGN
Evogene
$0.38
+0.2%
$0.46
$0.35
▼
$1.30
$3.27M1.441.10 million shs10,159 shs
CVR Partners, LP stock logo
UAN
CVR Partners
$125.72
+0.9%
$127.84
$93.43
▼
$139.50
$1.33B0.2654,323 shs7,234 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Evogene Ltd. stock logo
EVGN
Evogene
+2.91%+1.08%-1.47%-23.50%-71.42%
CVR Partners, LP stock logo
UAN
CVR Partners
+1.02%-1.51%+1.51%-2.13%+36.45%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Evogene Ltd. stock logo
EVGN
Evogene
1.00
SellN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
2.50
Moderate Buy$124.00-1.37% Downside

Current Analyst Ratings Breakdown

Latest UAN and EVGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/27/2026
CVR Partners, LP stock logo
UAN
CVR Partners
Initiated CoverageHold$124.00
10/2/2026
Evogene Ltd. stock logo
EVGN
Evogene
Reiterated RatingSell (E+)
8/11/2026
CVR Partners, LP stock logo
UAN
CVR Partners
Reiterated RatingBuy (B)
(Data available from 10/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Evogene Ltd. stock logo
EVGN
Evogene
$1.66M1.97N/AN/A$1.37 per share0.27
CVR Partners, LP stock logo
UAN
CVR Partners
$676.86M1.96$17.20 per share7.31$25.14 per share5.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Evogene Ltd. stock logo
EVGN
Evogene
-$8.48M-$0.91N/AN/AN/A-694.18%-156.53%-86.80%11/19/2026 (Estimated)
CVR Partners, LP stock logo
UAN
CVR Partners
$98.66M$15.168.28N/AN/A23.67%51.56%15.70%11/3/2026 (Confirmed)

Latest UAN and EVGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/19/2026Q3 2026
Evogene Ltd. stock logo
EVGN
Evogene
-$0.19N/AN/AN/A$0.37 millionN/A
11/3/2026Q3 2026
CVR Partners, LP stock logo
UAN
CVR Partners
$1.62N/AN/AN/A$165.40 millionN/A
7/29/2026Q2 2026
CVR Partners, LP stock logo
UAN
CVR Partners
N/A$7.33N/A$7.33N/A$202.19 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Evogene Ltd. stock logo
EVGN
Evogene
N/AN/AN/AN/AN/A
CVR Partners, LP stock logo
UAN
CVR Partners
$24.3219.34%N/A160.42%1 Years

Latest UAN and EVGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2026
CVR Partners, LP stock logo
UAN
CVR Partners
quarterly$6.0820.73%8/10/20268/10/20268/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Evogene Ltd. stock logo
EVGN
Evogene
N/A
3.57
3.54
CVR Partners, LP stock logo
UAN
CVR Partners
1.64
3.01
2.11

Institutional Ownership

CompanyInstitutional Ownership
Evogene Ltd. stock logo
EVGN
Evogene
10.40%
CVR Partners, LP stock logo
UAN
CVR Partners
43.83%

Insider Ownership

CompanyInsider Ownership
Evogene Ltd. stock logo
EVGN
Evogene
7.40%
CVR Partners, LP stock logo
UAN
CVR Partners
0.36%
CompanyEmployeesShares OutstandingFree FloatOptionable
Evogene Ltd. stock logo
EVGN
Evogene
528.72 million8.07 millionNo Data
CVR Partners, LP stock logo
UAN
CVR Partners
32010.57 million10.53 millionOptionable

Recent News About These Companies

Freedom Broker Initiates Coverage on CVR Partners (NYSE:UAN)
Reviewing Sumitomo Chemcl (OTCMKTS:SOMMY) & CVR Partners (NYSE:UAN)
CVR Partners, LP Q2 2026 Earnings Call Summary
CVR Partners Reports Second Quarter 2026 Results
CVR Partners, LP

New MarketBeat Followers Over Time

Media Sentiment Over Time

Evogene stock logo

Evogene NASDAQ:EVGN

$0.38 +0.00 (+0.16%)
As of 12:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

CVR Partners stock logo

CVR Partners NYSE:UAN

$125.72 +1.18 (+0.95%)
As of 12:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP is a subsidiary of CVR Energy, Inc.